{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:28:52Z","timestamp":1770964132144,"version":"3.50.1"},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[1997,5]]},"abstract":"<jats:p>Based on the difficulties experienced in the treatment of chromoblastomycosis, 12 primary human isolates of F. pedrosoi, were tested for their in vitro susceptibility to various antimycotics. We adapted the recommendations of the NCCLS for yeasts and followed the indications for mold testing from other authors in order to determine their MIC\u2019s and the MLC\u2019s. It was found that a significant proportion of the isolates were resistant to 3 of the 4 antimycotics tested, as revealed by high MIC values, as follows: 33% were resistant to amphotericin B (AMB), 58.3% to 5 fluocytosine (5 FC) and 66.7% to fluconazole (FLU). Contrarywise, none of the isolates proved resistant to itraconazole (ITZ). Determination of the MLC\u2019s revealed that a larger proportion of the isolates were not killed by AMB, 5 FC (91.7%), FLU (100%) or even, ITZ (41.7%). These data indicate that it would be desirable to determine the susceptibility of F. pedrosoi before initiating therapy, in order to choose the more effective antifungal and avoid clinical failure<\/jats:p>","DOI":"10.1590\/s0036-46651997000300004","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T13:24:18Z","timestamp":1114608258000},"page":"145-148","source":"Crossref","is-referenced-by-count":14,"title":["In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals"],"prefix":"10.1590","volume":"39","author":[{"given":"Catalina de","family":"BEDOUT","sequence":"first","affiliation":[{"name":"Corporaci\u00f3n para Investigaciones Biol\u00f3gicas (CIB)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz L.","family":"G\u00d3MEZ","sequence":"additional","affiliation":[{"name":"Corporaci\u00f3n para Investigaciones Biol\u00f3gicas (CIB)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"RESTREPO","sequence":"additional","affiliation":[{"name":"Corporaci\u00f3n para Investigaciones Biol\u00f3gicas (CIB)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/infdis\/170.2.384","article-title":"Correlation between in vitro and in vivo activity of antifungal agents against Candida species","volume":"170","author":"ANNAISIE E.J.","year":"1994","journal-title":"J. infect. Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref2","first-page":"118","article-title":"Correlation between in vitro and in vivo activity of antifungal agents against yeasts","volume":"6","author":"BILLE J.","year":"1996","journal-title":"J. Mycol. Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1590\/S0074-02761996000600026","article-title":"Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole","volume":"91","author":"CARDONA N.","year":"1996","journal-title":"Mem. Inst. Oswaldo Cruz","ISSN":"https:\/\/id.crossref.org\/issn\/0074-0276","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01138472","article-title":"Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species","volume":"128","author":"COLOMBO A.","year":"1994","journal-title":"Mycopathologia","ISSN":"https:\/\/id.crossref.org\/issn\/0301-486X","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0924-8579(95)00043-7","article-title":"Itraconazole: pharmacology, clinical experience and future development","volume":"6","author":"DEBEULE K.","year":"1996","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/JCM.29.2.393-394.1991","article-title":"Spectrophotometric method of inoculum preparation for the in vitro testing of filamentous fungi","volume":"29","author":"ESPINEL-INGROFF A.","year":"1991","journal-title":"J. clin. Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.39.2.314","article-title":"Comparative and collaborative evaluation of antifungal susceptibility testing for filamentous fungi","volume":"39","author":"ESPINEL-INGROFF A.","year":"1995","journal-title":"Antimicrob. Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"ref8","first-page":"S64","article-title":"Standardization of antifungal susceptibility testing: review update","volume":"13","author":"ESPINEL-INGROFF A.","year":"1996","journal-title":"Rev. Iberolatinamer. Micol."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4269\/ajtmh.1996.55.45","article-title":"Forty years of chromoblastomycosis in Madagascar: a review","volume":"55","author":"ESTERRE P.","year":"1996","journal-title":"Amer. J. trop. Med. Hyg.","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02681219280000911","article-title":"Standardization of antifungal susceptibility testing","volume":"30","author":"GALGIANI J.","year":"1992","journal-title":"J. med. vet. Mycol.","ISSN":"https:\/\/id.crossref.org\/issn\/0268-1218","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2165\/00003495-199039060-00006","article-title":"Fluconazole: a review of its pharmacokinetic properties and therapeutic potentials in superficial and systemic mycosis","volume":"39","author":"GRANT S.","year":"1990","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/JCM.34.3.489-495.1996","article-title":"Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome","volume":"34","author":"MAHMOUD A.G.","year":"1996","journal-title":"J. clin. Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref13","series-title":"Laboratory handbook of medical mycology","first-page":"570","volume-title":"Media and reagents","author":"MCGINNIS M.R.","year":"1980"},{"key":"ref14","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: Tentative standard M-27-T","year":"1995"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0891-5520(20)30531-6","article-title":"Antifungal susceptibility testing: current state of technology, limitations and standardization","volume":"7","author":"PFALLER M.A.","year":"1993","journal-title":"Infect. Dis. Clin. N. Amer."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1128\/AAC.40.9.2106","article-title":"Comparison study of broth susceptibility tests for the filamentous fungi","volume":"40","author":"PUJOL I.","year":"1996","journal-title":"Antimicrob. Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0190-9622(08)81277-7","article-title":"Treatment of tropical mycoses","volume":"31","author":"RESTREPO A.","year":"1994","journal-title":"J. Amer. Acad. Derm.","ISSN":"https:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CMR.6.4.367","article-title":"Antifungal susceptibility testing","volume":"6","author":"REX J.","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/35.6.793","article-title":"Correlation of in vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients","volume":"35","author":"RODRIGUEZ-TUDELA J.","year":"1995","journal-title":"J. Antimicrob. Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/02681219480000821","article-title":"Mechanisms and clinical impact of drug resistance","volume":"32","author":"VANDENBOSSCHE H.","year":"1994","journal-title":"J. med. vet. Mycol.","ISSN":"https:\/\/id.crossref.org\/issn\/0268-1218","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/02681219480000891","article-title":"Antifungal drug susceptibility testing","volume":"32","author":"VAN CUTSEM J.","year":"1994","journal-title":"J. med. vet. Mycol"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v39n3\/0027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T22:15:23Z","timestamp":1625868923000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46651997000300004&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["S0036-46651997000300004"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46651997000300004","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}